The development of a rapid diagnostic system for difficult to culture human pathogens by A Talip, Balkis
 
 
The Development of a Rapid Diagnostic System for Difficult to 
Culture Human Pathogens 
 
 
By 
Balkis A Talip, B.Sc.(Hons), M.Sc. 
 
 
 
In partial fulfilment of the requirements of the degree of Doctor of 
Philosophy 
 
 
May 2013 
School of Biomedical Sciences 
Faculty of Life and Health Sciences 
University of Ulster 
 
(I confirm that the word count of this thesis is less than 100,000)  
v 
 
LIST OF TABLES 
Table  Page 
1.1 An average estimation of the burden of disease caused by 
tuberculosis in 2011 reported by WHO. This summary has been 
adapted from Global Tuberculosis Report 2012 
(www.who.int/tb/publications/global_report/) and represents the 
rate per 100,000 populations
a 
(Dias et al. 2012). 
 
6 
1.2 An estimation of MDR-TB cases reported in 2011 from WHO 
regions. This data was adapted from the Global Tuberculosis 
Report 2012 (www.who.int/tb/publications/global_report/). Direct 
measurements are still in progress therefore, the data supplied is 
estimation from the actual incidence (Dias et al. 2012). 
 
9 
1.3 List of selected Mycobacterium spp. showing variation in size and 
genome composition from species to species. This data was 
analysed and summarized from Genome Atlas Database 
(http://www.cbs.dtu.dk/services/GenomeAtlas). 
 
14 
1.4 Most frequent human diseases caused by common RGM 
group/species. 
 
21 
1.5 Commercially available NAA assays for the detection of 
Mycobacterium spp. from clinical specimens. 
 
34 
3.1 List of primers used in this study for detection of M. smegmatis 
(NCIMB8548), environmental isolates VS/02 and genomic DNA 
from M. tuberculosis (ATCC
®
25177). 
 
99 
3.2 The purity and concentration of DNA extracted from archived 
slides by using the scraping techniques. 
 
117 
3.3 The DNA amplification correlates with fixation, staining and DNA 
extraction methods by using nested PCR. 
 
122 
3.4 Average of Cq value of samples detected using nested real-time 
PCR from primary amplicons of enumerated M. smegmatis cells 
catapulted from archived glass slides. The Cq values correlate with 
the numbers of cells successfully catapulted and primarily 
amplified using touchdown PCR. 
 
146 
 
 
 
vi 
 
LIST OF TABLES 
Table  Page 
3.5 The concentration and purity of DNA extracted using different 
methods and subjected to a pre-amplification step using MDA 
REPLI-g
®
 UltraFast Mini kit. 
 
151 
3.6 Comparison of the sensitivity for detection of rpoB gene from M. 
smegmatis cells, isolated from archived glass slides, using nested 
touchdown and nested real-time PCR detection
 
assay. 
 
155 
4.1 List of primers used in this study for detection of M. smegmatis 
(NCIMB8548) for RNA based work. 
 
184 
4.2 The concentration and purity of RNA extracted from two isolates of 
M. smegmatis and determined using the NanoDrop 2000 
spectrophotometer. 
 
194 
4.3 The concentration and purity of RNA extraction using combined 
methods of Lysing matrix-A step, GeneJet kit, gDNA eliminator 
spin column (RNAeasy Plus Mini kit) and “on-column” DNase 
treatment from M. smegmatis (NCIMB 8548), fixed on glass slides 
and quantified using the NanoDrop 2000 spectrophotometer. 
 
196 
4.4 The Cq values of primary amplicons detected using 16S rRNA gene 
specific primers for nested real-time PCR. The Cq values correlate 
with the RNA extracted from M. smegmatis fixed on glass slides by 
different types of slide processing, isolated and primarily amplified 
using PCR. 
 
201 
4.5 The Cq values of the primary amplicons detected using rpoB gene 
specific primers for nested real-time PCR. The Cq values correlate 
with the RNA extracted from M. smegmatis fixed on glass slides by 
different type of slides processing isolated and primarily amplified 
using PCR. 
 
206 
4.6 The Cq values of cDNA amplification using a 16S rRNA-sequence-
specific probe. The Cq values correlate with the RNA extracted 
from M. smegmatis fixed on glass slides, by different types of slide 
processing, isolated and primarily amplified using PCR. 
 
 
211 
 
vii 
 
LIST OF FIGURES 
Figure  
 
Page 
1.1 The incident rate of tuberculosis, reported from 1990 to 2011, 
from 22 classified high burden countries (HBCs) within the 
WHO region (Dias et al. 2012). These figures indicate that the 
tuberculosis incidence has been falling since the peak 
recorded in mid-1990s among 22 HBCs. This was for most 
countries except for several regions of Africa as shown from 
the graph pattern. 
 
7 
1.2 An estimated number of tuberculosis and death (in millions) 
reported between 1990 to 2011 globally (Dias et al. 2012). 
The falling rates of tuberculosis cases are shown globally 
from mid-2000. Despite the number of tuberculosis incidence 
cases increasing, death rates have been reportedly declining 
every year. 
 
8 
1.3 Schematic diagram of Mycobacterium showing the main 
components of the outer and inner layer of cell walls. The 
presence of mycolic acid in the complex of covalent-linked 
MA-AG-PG is a unique character for identification of the 
genus Mycobacterium and plays an important role as a 
permeability barrier (Medjahed, Gaillard & Reyrat 2010). 
 
13 
1.4 The flow-chart shows natural cause progression of 
tuberculosis and general plan-of-detection in 
immunocompetent and immunocompromised individual 
following exposure to tubercle bacilli by inhalation. 
 
17 
2.1 (a - b) The morphology of M. smegmatis observed on Nutrient agar 
plates after 48 hours incubation at 37
o
C. (a) The small 
colonies with a white to yellow colour were observed on the 
Nutrient agar plate; (b) Negative control of sterile Nutrient 
agar in which no colonies had grown. 
 
51 
2.2 (a - d) The M. smegmatis observed in broth growth media. Changes 
of broth turbidity were compared with the non-inoculated 
broth media (-ve control) incubated for 24 and 48 hours at 
37
o
C. Pellicle and sediment were observed in both broth 
media inoculated by colonies and culture suspension 
respectively after 24 hours incubation. The sedimentation was 
obvious in the BHI broth after 48 hours. (a) The M. 
smegmatis grown in Nutrient broth observed after 24 hours; 
(b) The M. smegmatis grown in Nutrient broth observed after 
48 hours; (c) The M. smegmatis grown in BHI broth observed 
after 24 hours; (d) The M. smegmatis grown in BHI broth 
observed after 48 hours. 
 
52 
viii 
 
 LIST OF FIGURES  
Figure  Page 
2.3 (a - b) The M. smegmatis cells incubated for 48 hours, observed 
under the LCM at 63× magnification. (a) The red coloured of 
M. smegmatis cells stained by using standard Ziehl-Neelsen 
procedures; (b) The colourless and the very light-red coloured 
M. smegmatis cells stained by using 37
o
C carbol-fucshin dye 
solution. 
 
55 
2.4 Growth curve of M. smegmatis in Nutrient and BHI broth 
measured by optical density (OD600) versus incubation time 
(hour). The doubling time is shown by the dashed arrow for 
both growth media. The t1 was 24 hours post-inoculation and 
t2 was the end of exponential growth. 
 
57 
2.5 (a – b) Ziehl-Neelsen stained slides of M. smegmatis isolating 
process. This uses a scraping technique and showed that the 
largest amount of cells were recovered from the slides 
observed under LCM at 63× magnification. (a) Smear before 
isolation; (b) Smear after isolation by using the scraping 
method. 
 
59 
2.6 (a – b) LPC application of LCM performed on the un-smeared 
PALM
®
 PEN-membrane slide which ensures the efficiency of 
LPC or the laser-cutting (microdissection) application. (a) 
Prior to laser pulse being applied; (b) LPC application applied 
shown by black arrows indicating the laser function. 
 
62 
2.7 (a – b) The M. smegmatis smear was mounted and stained by using 
the Ziehl-Neelsen standard method on a PALM
®
 PEN-
membrane slide which was observed and isolated at 63× 
magnification. (a) M. smegmatis cells before LPC; (b) M. 
smegmatis cells after LPC. 
 
63 
2.8 (a - b) Isolation of M. smegmatis cells from a thick smear Ziehl-
Neelsen stained slide observed and isolated at 63× 
magnification. (a) Thick smear Ziehl-Neelsen slides before 
any laser pulses have been applied; (b) The laser-cutting or 
microdissection application was used on the smear and 
showed a slightly clear zone indicated by the black arrow. 
The LPC application is shown by white arrow. 
 
 
 
 
 
 
 
 
 
66 
ix 
 
 LIST OF FIGURES  
Figure  Page 
2.9 (a - c) Isolation of M. smegmatis cells fixed and stained by Ziehl-
Neelsen standard protocols. The cells were observed and 
isolated from the glass slides by using LPC application at 63× 
magnification. (a) M. smegmatis cells before catapulting; (b) 
The clear zone has shown the cells were catapulted by LPC; 
(c) The PCMs collected in the ddH2O was re-examined at 63 
× magnification with no re-staining. 
 
67 
2.10 (a - c) M. smegmatis cells stained by Ziehl-Neelsen observed and 
isolated from glass slides using the 63× magnification of 
LCM. (a) Ziehl-Neelsen stained slides before catapulting; (b) 
The selected area was catapulted by using LPC application; 
(c) PCMs collected in the PTA was re-examined to ensure 
cells were successfully collected. 
 
72 
2.11 (a - c) The PCMs of individual M. smegmatis cells observed under 
TEM and catapulted into 1% PTA from archived glass slides. 
(a) Several catapulted individual cells; (b) Several different 
shapes of post-catapulted cells; (c) An intact single cell 
successfully catapulted and isolated using LPC. 
 
74 
2.12 (a - b) A M. smegmatis cell grown and isolated from the Nutrient 
broth (48 hours, 37
o
C). This was used to compare the shape 
and dimension with the PCMs isolated by LCM. (d) Several 
M. smegmatis cells with slight different dimensions; (e) a 
single cell of M. smegmatis. 
 
76 
2.13 (a - b) LPC application for isolating Gram-negative bacteria P. 
aeruginosa PAO1 fixed and stained by Gram-staining on 
glass slides at 63× magnification. (a) P. aeruginosa PAO1 
stained smear before catapulting; (b) The catapulting action 
has removed the top layer of the smear displaying different 
colour intensity at the catapulting zone compared to (a). 
 
79 
2.14 (a - b) Gram-stained slides of mixed bacteria cultures (P. aeruginosa 
PAO1 and M. smegmatis). These showed that the LPC 
application is able to isolate different type of bacterial cells. 
(a) The mixed-cultures of bacteria before catapulting; (b) The 
mixed-culture of bacteria after catapulting. LPC was used to 
isolate cells of interest selectively. 
 
 
 
 
 
 
 
 
80 
x 
 
 LIST OF FIGURES  
Figure  Page 
3.1 (a - c) The agarose gel electrophoresis (1.5%) shows the 
amplification of DNA extracted from M. smegmatis 
(NCIMB8548), environmental isolate (VS/02) and genomic 
DNA from M. tuberculosis (ATCC
®
 25177). (a) Primary PCR 
using primers BMS738aF and 1311R amplified a 599 bp 
product; (b) Nested PCR using primers BnMS1100bf and 
1184br amplified 103 bp product; (c) Nested PCR using 
primer BnMS949bf and 1105br which amplified a 179 bp 
product. Lanes 1 and 6: 100 bp ladder, lane 2: M. smegmatis 
(NCIMB8548), lane 3: environmental isolate (VS/02), lane 4: 
genomic DNA M. tuberculosis and lane 5: negative control. 
 
109 
3.1 (d - e) The agarose gel electrophoresis (1.5%) shows the 
amplification of DNA extracted from M. smegmatis 
(NCIMB8548), environmental isolate (VS/02) and genomic 
DNA from M. tuberculosis (ATCC
®
 25177). (d) Primary PCR 
using primers MS-rpoB-F2 and R2 which amplify a 450 bp 
product; (e) Nested PCR using primers MS(in-9) rpoB-F and 
R which amplify a 148 bp product. Lanes 1 and 6:100 bp 
ladder, lane 2: M. smegmatis (NCIMB8548), lane 3: 
environmental isolate (VS/02), lane 4: genomic DNA from M. 
tuberculosis (ATCC
®
 25177) and lane 5: negative control. 
 
111 
3.1 (f - g) The agarose gel electrophoresis (1.5%) shows the 
amplification of DNA extracted from M. smegmatis 
(NCIMB8548), environmental isolate (VS/02) and genomic 
DNA from M. tuberculosis (ATCC
®
 25177). (f) Primary PCR 
using primers MycoF and R which amplify a 764 bp product; 
(g) Nested PCR by using primers Myco-F7-in and R7-in 
which amplify a 271 bp product. Lanes 1 and 6:100 bp ladder, 
lane 2: M. smegmatis (NCIMB 8548), lane 3: environmental 
isolate (VS/02), lane 4: genomic DNA from M. tuberculosis 
(ATCC
®
 25177) and lane 5: negative control. 
 
112 
3.2 Correlation of DNA concentration of unstained slides with 
extraction and fixation methods. 
 
116 
3.3 Correlation of DNA concentration with staining and 
extraction methods from air-dried slides. 
 
120 
3.4 Correlation of DNA concentration with staining and 
extraction methods from heat-fixed slides. 
 
 
 
 
 
 
121 
xi 
 
 LIST OF FIGURES  
Figure   Page 
3.5 (a - e) Agarose gel electrophoresis showing an approximate 176 bp 
nested PCR product amplified with primers BnMS949bf and 
1105br. DNA was extracted by using different extraction 
method. (a) DNA extracted from Ziehl-Neelsen (hot stain) 
stained slides; (b) DNA extracted from Ziehl-Neelsen (37
o
C 
stain) stained slides; (c) DNA extracted from Mycobacteria 
fluorescent stain kit stained slides; (d) DNA extracted from 
Gram-stained slides; (e) DNA extracted from unstained 
slides. The 100 bp ladder showed in lanes 1 and 12. Lanes 2 
to 5 showing the air-dried samples and 8 to 11 showing the 
heat-fixed samples. Lanes 2 and 8: heat-shock; lanes 3 and 9: 
heat-shock followed by ethanol precipitation; lanes 4 and 10: 
QIAamp
®
 DNA Micro kit; lane 5 and 11: Chelex-100; lane 6: 
negative control; lane 7: positive control. 
 
124 
3.6 (a - b) Dual parameter dot plot (i) and histogram (ii) showing the 
distribution of FSC and dual-staining uptake of an 
exponential culture of bacteria. The red and green colour of 
the dot plot indicated TO (0.5 µg/ml) and PI (1.3 mg/ml) 
taken up by cells. The FSC determined the size of cell ranging 
from 0.5 to 40 µm (a) The total number of M. smegmatis cells 
- 489,420 enumerated from 15 µl culture; (b) The total 
number of P. aeruginosa PAO1 cells - 438,525 enumerated 
from 15 µl cultures. The histogram (ii) indicated that all cells 
were determined and there was no interference from 
background noise. 
 
127 
3.7 (a - b) The observation of post-enumerated bacteria cell cultures 
under the fluorescence microscope, 40× magnification using 
blue light for excitation. Results indicate that targeted bacteria 
cells were stained using TO (0.5 µg/ml) and PI (1.3 mg/ml). 
The green and red staining represents live and dead cells 
respectively. (a) Population of M. smegmatis cells showing 
live and dead cells; (b) Population of P. aeruginosa PAO1 
cells showing live and dead cells. 
 
128 
3.8 (a - b) This figure shows that it is possible to enumerate pre-stained 
cells recovered from glass slides using FCM. The cells were 
isolated using LCM and were stained with TO (0.5 µg/ml) 
and PI (1.3 mg/ml). The incubation time was 40 minutes at 
room temperature to allow for the dyes absorption into the 
cell wall before employing the FCM. (a) A dot plot (i) 
analysis demonstrates the uptake of FCM staining dyes by 
PCMs. The histogram (ii) analysis indicates various sizes of 
samples for enumeration; (b) P. aeruginosa PAO1 catapulted 
cells from Gram-stained glass slides. 
 
 
131 
xii 
 
 LIST OF FIGURES  
Figure   Page 
3.9 (a – c) Observations of post-enumerated samples under the 
fluorescence microscope, 40 × magnifications, using blue 
light for excitation. The results indicate the prolonged 
incubation time has increased the pre-stained PCMs cells 
permeability to absorb the dyes showed by arrow. (a) M. 
smegmatis; (b) P. aeruginosa PAO1; (c) The background with 
the unclear staining indicates that, several cells could not 
allow the dye absorption resulting in dye diffusion. 
 
132 
3.10 (a – f) A 10-fold serial dilution of catapulted M. smegmatis cells 
stained using TO (0.5 µg/ml) and PI (1.3 mg/ml) which are 
subjected to FCM for enumeration. The dot plot analysis (i) 
shows that the cells were enumerated according to the dilution 
factor. The total number of cells per µl is reduced for each 
counting. The dual-parameter histogram (SSC versus FSC) 
shows uniformity of a bell-shape peak and indicates the 
subjected PCMs were enumerated without background 
interference (a) 10
-1 
(b) 10
-2
 (c) 10
-3
 (d) 10
-4
 (e) 10
-5
 (f) 10
-6
. 
 
135 
3.11 (a - e) A set of catapulted Ziehl-Neelsen stained M. smegmatis cells 
isolated from glass slides using LCM. The pre-stained M. 
smegmatis cells were stained with TO (0.5 µg/ml) and PI (1.3 
mg/ml). The incubation time was 40 minutes at room 
temperature to allow the dye absorption into the M. 
smegmatis cell wall before employing the FCM. The post-
enumerated cells were collected and subjected to DNA 
extraction to ensure the amplifiable DNA was recovered. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
138 
xiii 
 
 LIST OF FIGURES  
Figure   Page 
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3.14 (a - b) A agarose gel electrophoresis (1.5%, 4
o
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using REPLI-g
®
 UltraFast Mini kit of catapulted M. 
smegmatis cells, isolated from archived glass slides using 
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reaction; (b) 1:25 dilution of post-MDA reaction. Lanes 1 and 
6: 100 bp ladder; lane 2: heat-shock; lane 3: heat-shock 
followed by ethanol precipitation; lane 4: QIAamp
®
 DNA 
Micro kit; lane 5: positive control; lane 6: negative control 
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visible product on agarose gel electrophoresis (1.5%, 4
o
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Amplification was performed using an undiluted post-MDA 
reaction; (b) Amplification was performed using the 1:25 
dilution of post-MDA reaction. Lanes 1 and 7: 100 bp ladder; 
lane 2: heat-shock; lane 3: heat-shock followed by ethanol 
precipitation; lane 4: QIAamp
®
 DNA Micro kit; lane 5: 
positive control; lane 6: negative control. 
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3.16 (a - b) A nested touchdown PCR of post-MDA reaction showing 
non-visible or a low intensity 176 bp product on agarose gel 
electrophoresis (1.5%, 4
o
C). (a) The primary PCR was 
performed using an undiluted post-MDA reaction in which no 
amplification product was observed; (b) The primary PCR 
was performed using a 1:25 dilution of post-MDA reaction 
showing low intensity of amplification at lanes 2 and 3. Lanes 
1 and 7: 100 bp ladder; lane 2: heat-shock; lane 3: heat-shock 
followed by ethanol precipitation; lane 4: QIAamp
®
 DNA 
Micro kit; lane 5: positive control; lane 6: negative control. 
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3.17 (a - c) Nested real-time PCR using primers BnMS949bf and 1105br 
for the detection of 30 M. smegmatis cells isolated from glass 
slides. The post-MDA reaction was primarily amplified by 
touchdown PCR using an undiluted post-MDA reaction 
amplicons. The undiluted primary amplicon was used as a 
template for the nested real-time PCR detection system. The 
analysis was carried out based on different DNA extraction 
methods; i: heat-shock; ii: heat-shock followed by ethanol 
precipitation; iii: QIAamp
®
 DNA micro kit. (a) The Cq pattern 
of amplification showed the detection of samples at different 
Cq values. A dilution (10
-6
) of the positive control was used to 
increase the efficiency of detection; (b) Tm Calling analysis 
showed two melting peaks generated from the melting curve 
after amplification. The products were then analysed using 
agarose gel electrophoresis; (c) Agarose gel electrophoresis 
(1.5%, 4
o
C) shows the 176 bp nested real-time product. Lanes 
1 and 7: 100 bp ladder; lane 2: heat-shock; lane 3: heat-shock 
followed by ethanol precipitation; lane 4: QIAamp
®
 DNA 
Micro kit; lane 5: positive control; lane 6: negative control.  
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3.18 (a - c) Nested real-time PCR using primers BnMS949bf and 1105br 
for the detection of 30 M. smegmatis cells isolated from glass 
slides. A template from the post-MDA reaction, primarily 
amplified using touchdown PCR was used. The primary 
amplification was performed using the 1:25 dilution of post-
MDA reaction and an undiluted amplicon was used for nested 
real-time PCR detection system. The analysis was carried out 
based on different DNA extraction methods; i: heat-shock; ii: 
heat-shock followed by ethanol precipitation; iii: QIAamp
®
 
DNA micro kit. (a) The Cq pattern of amplification showed 
the detection of samples at different Cq value. The diluted (10
-
6
) positive control was used to increase the efficiency of 
detection; (b) A single peak of Tm Calling analysis indicates 
that the product was specifically amplified. The products were 
further analysed using agarose gel electrophoresis; (c) 
Agarose gel electrophoresis (1.5%, 4
o
C) shows the 176 bp 
nested real-time PCR amplification product. Lanes 1 and 7: 
100 bp ladder; lane 2: heat-shock; lane 3: heat-shock followed 
by ethanol precipitation; lane 4: QIAamp
®
 DNA Micro kit; 
lane 5: positive control; lane 6: negative control. 
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3.19 The Cq pattern comparison analysis of nested real-time PCR 
post-detection by using Cq values obtained from amplification 
of undiluted and diluted (1:25) post-MDA reaction amplicons. 
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4.1 The agarose gel electrophoresis (1.0%, 4
o
C) shows the 23S 
and 16S rRNA extracted from total RNA of M. smegmatis 
(NCIMB8548) and environmental isolates (VS/02) cultures 
using three kinds of extraction method. The amplicon 
brightness and the smears shown on the gel are associated 
with the RNA extraction method used and the RNA 
degradation due to the presence of chromosomal DNA 
(ChDNA). Lane 1: 1 kb ladder, lanes 2 and 3: NCIMB8548 
and VS/02 extracted using GeneJET RNA purification kit, 
lanes 4 and 5: NCIMB8548 and VS/02 extracted using 
combined methods of Lysing matrix-A, gDNA eliminator 
spin column (RNeasy Plus Mini kit) and GeneJET RNA 
purification kit, lanes 6 and 7: NCIMB8548 and VS/02 
extracted using combination methods of Lysing matrix-A, 
gDNA eliminator spin column (RNeasy Plus Mini kit), 
GeneJET RNA purification kit and “on-column” DNase 
treatment. 
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4.2 The agarose gel electrophoresis (1.0%, 4
o
C) showing the 23S 
and 16S rRNA extracted from total RNA of M. smegmatis 
(NCIMB8548) isolated from glass slides using combined 
methods of Lysing matrix-A, gDNA eliminator spin column 
(RNeasy Plus Mini kit), GeneJET RNA purification kit and 
“on-column” DNase treatment. The low amplicon brightness 
shown on the gel could be due to the RNA degradation. Lane 
1: 1 kb ladder, lane 2: Ziehl-Neelsen stained slide sample, 
lane 3: frozen-Ziehl-Neelsen stained slide sample, lane 4: 
unstained slide sample. 
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4.3 (a – c) Nested real-time PCR of M. smegmatis (NCIMB8548) cells 
isolated from glass slides using 16S rRNA gene-specific 
primers. (a) The Cq of primary amplicons observed at cycle 
25; (i) Ziehl-Neelsen stained slide sample (ii) frozen-Ziehl-
Neelsen stained slide sample (iii) unstained slide sample (iv) 
positive control (v) negative contol (NTC); (b) Tm Calling 
analysis showing a single narrow peak of amplification 
product. The stable DNA amplification is shown by melting 
curve analysis with no by-product generated during the 
process; (c) Agarose gel (1.5%, 4
o
C) showing 166 bp nested 
real-time PCR amplified product. Lanes 1 and 7: 100 bp 
ladder, lane 2: Ziehl-Neelsen stained slide sample, lane 3: 
frozen-Ziehl-Neelsen stained slide samples, lane 4: unstained 
slide samples, lane 5: positive control, lane 6: negative control 
(NTC). 
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4.4 (a – c) Nested real-time PCR of M. smegmatis (NCIMB 8548) cells 
isolated from glass slides using rpoB gene-specific primers. 
(a) The Cq of primary amplicons observed at cycle 30; (i) 
Ziehl-Neelsen stained slide sample (ii) frozen-Ziehl-Neelsen 
stained slide sample (iii) unstained slide samples (iv) positive 
control (v) negative contol (NTC); (b) Tm Calling analysis 
showing an additional weak, broad peak with Tm of 77
o
C 
which arose from a non-specific by product from the 
unstained sample labelled iii (red line). (c) Agarose gel (1.5%, 
4
o
C) showing a 176 bp nested real-time PCR product 
amplified. Lanes 1 and 7: 100 bp ladder, lane 2: Ziehl-
Neelsen stained slide sample, lane 3: frozen-Ziehl-Neelsen 
stained slide sample, lane 4: unstained slide sample, lane 5: 
positive control, lane 6: negative control (NTC). 
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4.5 (a – b) Amplification of cDNA of M. smegmatis (NCIMB 8548) cells 
isolated from glass slides using a 16S rRNA-sequence-
specific probe. (a) The Cq has shown the cDNA was amplified 
from all samples and the first detection was visible at Cq >20; 
(i) Ziehl-Neelsen stained slide sample (ii) frozen-Ziehl-
Neelsen stained slide sample (iii) unstained slide sample (iv) 
positive control (v) negative contol (NTC); (b) Agarose gel 
(1.5%) showing the amplified 67 bp nested real-time PCR 
product. Lanes 1 and 7: 50 bp DNA ladder, lane 2: Ziehl-
Neelsen stained slide sample, lane 3: frozen-Ziehl-Neelsen 
stained slide sample, lane 4: unstained slide sample, lane 5: 
positive control, lane 6: negative control (NTC). 
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5.1 Flow-chart of conventional detection system for MTBC 
versus system model developed in this study. 
226 
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ABSTRACT 
The World Health Organization (WHO) has outlined a TB-free World 
strategy that aims to reduce tuberculosis prevalence by 2015. That could be achieved 
through the development of a specific and rapid detection system. In countries with a 
high incidence of tuberculosis, detection is solely based on sputum smear 
microscopy using Ziehl-Neelsen stain and chest radiography. This is followed by 
cultivation, which requires up to 12 weeks for confirmation. The diagnostic test 
available is insensitive, laborious, lacks specificity and does not even give 
unequivocal proof of infection. Consequently, this study was conducted to obtain 
confirmatory diagnostic information from Ziehl-Neelsen stained smears on glass 
slides. The fast-grower, non-pathogenic Mycobacterium smegmatis was used as the 
model organism due to similarity to the pathogenic strain, Mycobacterium 
tuberculosis. Laser capture microscopy (LCM) is primarily used as a microdissection 
tool in studies involving tissues and membranes. This technology was able to isolate 
intact individual cells fixed on archived glass slides regardless of how the smears 
and staining have been performed, confirmed by transmission electron microscopy 
(TEM) observation. Typically between 100 – 1,000 catapulted cells are enumerated 
using flow cytometry (FCM). A series of DNA extraction techniques which are heat-
shock, heat-shock followed by ethanol precipitation and QIAamp
®
 DNA Micro kit 
were compared and optimized for the lowest number of post-catapult cells. To 
maintain the detection of lowest number of catapulted cells, the rpoB-gene specific 
primers were designed for amplification using nested real-time PCR. Routinely, this 
system was able to detect as few as 30 catapulted cells per assay. This result 
demonstrated that it is possible to isolate the bacteria from glass slides and 
subsequently perform downstream molecular applications regardless of any 
xix 
 
inhibitory factors. In conclusion, we strongly recommend that this system may offer 
improved specificity and speed of tuberculosis detection with lower risk of exposure 
to infection through the use of stained slides. 
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General introduction. 
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1.1 An overview of the global tuberculosis (TB) incidence. 
Tuberculosis is a major health problem caused by Mycobacterium 
tuberculosis complex (MTBC) with many new cases reported each year which claim 
almost 2 million deaths (Dagnew et al. 2012, Dias et al. 2012). Many countries are 
affected by tuberculosis (Table 1.1). In 2011, 85% of cases were reported from 
Africa and Asia with the major prevalence, 59%, contributed from India and China 
alone. Meanwhile, a small proportion of tuberculosis incidence reported was by the 
Americas (3%), the European region (4.3%), Eastern Mediterranean (7.7%) and 
Western Pacific (21% (reported in 2010) (Dias et al. 2012, Small 2012). 
Tuberculosis is ranked as the eighth leading cause of death in low- and middle 
income countries. However, it becomes the third biggest killer after HIV/AIDS and 
ischemic heart disease among adult populations (age 15 to 59) (Lessells et al. 2011, 
Noens et al. 2011, Balakrishnan et al. 2012). M. tuberculosis infection is transmitted 
by the inhalation of infected aerosol droplets generated by people with pulmonary 
disease, through coughing. Transmission by other methods has not been reported. 
Although tuberculosis is curable, the available treatment regimes slow the 
infection rate but do not eliminate this infection from the population. This is 
indicated when reported tuberculosis cases continued to increase every year even 
though the number per 100,000 population decreased by 1% (Dias et al. 2012, 
Fitzpatrick et al. 2012). Treatment, using first-line drugs to treat M. tuberculosis 
among susceptible patients, does have an effect within 6 months. For the non-
susceptible patient, second-line drug treatments are introduced which are used to 
treat multidrug-resistant tuberculosis (MDR-TB) strains (Ahmad 2011). Despite the 
presence of second-line drugs which are able to overcome non-susceptible patients, 
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the high cost and side effects of their use result in cases of MDR-TB not being 
eradicated.  
Tuberculosis cases also relate to the spread of HIV/AIDS. In the 22 high-
burden countries (HBCs) classified by WHO (accounting for 80% of tuberculosis 
cases) showed the tuberculosis cases reported from 1990 to 2011 are mostly 
contributed from the HIV-positive patient (Figure 1.1) (Dias et al. 2012, Fitzpatrick 
et al. 2012). According to WHO, one in four deaths from tuberculosis is HIV related. 
The diagnoses of HIV-positive patients are more difficult to treat as opposed to non-
HIV-positive patients. In 2007, almost 1.37 million new tuberculosis cases were 
reported among HIV infected people alone. In addition, due to the low curable rate 
of people living with HIV, the mortality rate increased among these cases. The 
highest number of HIV-related tuberculosis cases peaked in Africa during the 1980s 
and steadily increased to 2004 (Blanc et al. 2009). The extensive treatment and 
monitoring then slowed the epidemic. Although new tuberculosis cases had 
reportedly decreased among the WHO region, the absolute numbers of cases 
increased along with the growth of population. 
From 2009 to 2011, the majority of tuberculosis incidence and deaths were 
reported from less-developed regions of world countries with the highest death rates 
recovered from the poorest region of Africa, India, China and Southeast Asia 
(approximately 20 to 40 per 100,000 population) (Small 2012, Fitzgerald, Sterling & 
Haas 2010). This may be due to low income countries having limited access to 
health-care systems, high exposure to unhealthy dwelling, poor-nutrition, HIV 
infection, diabetes mellitus, and unhealthy life styles like smoking and drug abuse 
(El Khechine et al. 2009, Balakrishnan et al. 2012). Dating from 1990, the post-
communist Eastern European region and former Soviet Union countries, were also 
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known as high tuberculosis burden areas where reported cases increased until 1998 
(approximately 20 to 40 rates per 100,000 population). There was a decline of 8.5% 
in mortality rate shown from 1998 to 2011 (Dias et al. 2012). This trend has been 
related to improvements in political and socio-economic status of former Soviet 
Union dependents. Globally, mortality rates of tuberculosis are successfully 
decreasing as reported in 2011 among 22-HBCs (Figure 1.2). 
The rise of MDR-TB and extensively drug-resistant TB (XDR-TB) cases 
have become a major concern of the WHO. This may be due to the determination of 
successful current strategic planning to control the spread of disease. There were an 
estimated 630,000 cases of MDR-TB among the world’s 12 million tuberculosis 
cases reported in 2011. The actual number of cases and incidence trend is currently 
under investigation (Dias et al. 2012). Therefore the assessment of data for each 
country is still not fully accessible. However, an estimated number of MDR-TB 
cases reported, based on region, has been provided by WHO. Data was obtained 
from affected countries (Table 1.2). This surveillance data is crucial due to the 
chronic effects of MDR-TB infection.  
Existing diagnostic methods for MDR-TB are slower and take longer to 
perform in comparison to diagnostics for MTBC common infection. Second-line 
drug treatment for MDR-TB is expensive due to the long treatment regime required 
to ensure effectiveness and prevent recurring infections. Although the death rate 
recorded in the WHO region from 1990 to 2011 has decreased, the actual number of 
deaths from HIV-related tuberculosis cases still may be greater than recorded. This 
may be due to no tuberculosis diagnosis from HIV patients but in such cases death is 
often not recorded as deaths due to tuberculosis. Many studies indicated that tackling 
the prominent factors of tuberculosis incidence allows the improvement of 
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tuberculosis controls. This involves many different intervention strategies which are 
largely dependent on political power and public awareness. 
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Table 1.1: An average estimation of the burden of disease caused by tuberculosis in 
2011 reported by WHO. This summary has been adapted from the Global 
Tuberculosis Report 2012 (www.who.int/tb/publications/global_report/) and 
represents the rate per 100,000 population
a 
(Dias et al. 2012). 
 
Region 
 
Population 
(thousand) 
 
Mortality
b
 
 
Prevalence 
 
Incidence 
 
HIV prevalence 
in incident TB 
cases (%) 
Africa 857,382 26 293 262 41 
America 943,039 2.2 35 28 17 
Eastern 
Mediterranean 
608,628 16 170 109 2.1 
European 899,500 5.0 56 42 8.0 
Southeast Asia 1,830,361 26 271 189 5.0 
Western Pacific 1,808,797 6.9 138 92 3.1 
 
Note: 
a
 = The value is the point categorized as “best” estimation at lower and upper bounds 
of the 95% uncertainty interval. 
b
 = Mortality excludes deaths among HIV-positive tuberculosis cases. Deaths among 
HIV-positive tuberculosis cases are classified as HIV deaths according to the 
International Classification of Diseases (ICD-10). 
. 
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Figure 1.1: The incident rate of tuberculosis, reported from 1990 to 2011, from 22 
classified high burden countries (HBCs) within the WHO region (Dias et al. 2012). 
These figures indicate that the tuberculosis incidence has been falling since the peak 
recorded in the mid-1990s among 22 HBCs. This was for most countries except for 
several regions of Africa as shown from the graph pattern.  
 
 
 
Green line = estimated tuberculosis incidence  
Red line = HIV-positive TB related cases. 
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Figure 1.2: An estimated number of tuberculosis cases and death (in millions) 
reported between 1990 to 2011 globally (Dias et al. 2012). The falling rates of 
tuberculosis cases are shown globally from mid-2000. Despite the number of 
tuberculosis cases increasing, death rates have been reportedly declining every year. 
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Table 1.2: An estimation of MDR-TB cases reported in 2011 from WHO regions. 
This data was adapted from the Global Tuberculosis Report 2012 
(www.who.int/tb/publications/global_report/). Direct measurements are still in 
progress therefore, the data supplied is an estimation of the actual incidence (Dias et 
al. 2012).  
     
Region Estimation of 
new TB cases 
with MDR-TB 
(%) 
Confidence 
interval 
Estimation of 
previous 
treated TB 
cases with 
MDR-TB (%) 
Confidence 
interval 
Africa 2.9 0.1-6.2 11 3.4-18 
America 2.0 0.8-3.3 11 4.5-18 
Eastern 
Mediterranean 
3.4 0.1-10 30 6.9-53 
European 5.1 10-20 44 40-49 
Southeast Asia 2.1 1.8-2.5 16 12-19 
Western Pacific 4.8 3.4-6.1 22 18-26 
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1.2 Description of the genus Mycobacterium. 
Currently, there are almost 200 mycobacterial species that have been 
described by molecular techniques (Pfyffer, Palicova 2011). Mycobacterium is the 
only genus in the family of Mycobacteriacea. This aerobic bacterium contains 
various morphological shapes based on growth condition. Some species such as 
Mycobacterium smegmatis and M. tuberculosis are able to grow in a limited oxygen 
environment. It has typical rod-shape or slightly curve with cell dimensions of 0.2 to 
0.6 µm by 1 to 10 µm (Pfyffer, Palicova 2011).  
This genus cell wall is unique and contains a high proportion of a complex 
lipid that prevents access of common aniline dyes. This complex cell wall comprises 
an outer and inner compartment. The outer compartment contains protein and lipid. 
The lipid-linked polysaccharides (outer cell wall) consist of lipoarabinomannan 
(LAM), lipomannan, phthiocerol dimycocerosate, trehasole and phosphatidylinositol 
mannoside (Draper 1998, Hett, Rubin 2008). In addition, the sulfolipid is only 
present in M. tuberculosis. The outer compartment of the cell wall is soluble and has 
a role for interacting with the host immune system. The insoluble inner compartment 
of the cell wall consists of peptidoglycan (PG), arabinogalactan (AG) and mycolic 
acid (MA). These are linked together by covalent bonds and contribute to the core 
component of mycobacteria cell wall (Cole et al. 1998, Draper 1998, Toney et al. 
2010).  
Mycobacteria are grouped neither as Gram-positive nor Gram-negative 
bacteria. They have some unique qualities that are divergent from members of the 
Gram-positive group, which is that the cell wall contains mycolic acids. A 
prototypical Gram-positive bacterial cell wall contains a thick PG layer (10 to 20 
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sheets) with a size range of 20 to 80 nm for each sheet. This is contrary to a Gram-
negative bacterial cell wall which consists of 1 to 10 thin layers (approximately 10 
nm thickness of each layer) of PG (Figure 1.3). In contrast, a Mycobacterium cell 
wall consists of between 4 to 15 nm thickness of PG associated with teichoic acids, 
lipoteichoic acids and MAs which does not significantly show a distinctive layer of 
PG (Brennan 2003, Hett, Rubin 2008).  
Mycobacteria are commonly described as acid-fast, implying that after 
staining they resist decolourization with acidified alcohol and also with strong 
mineral acid. The common staining procedure used is Ziehl-Neelsen staining 
(Pfyffer, Palicova 2011) which makes the bacteria stain red. The property of acid-
fast, due to the waxy materials in the cell walls is particularly important to 
recognizing the Mycobacterium genus and primarily determines the permeability of 
cell walls. It is composed of α-alkyl and long β-hydroxyl-fatty acids (60 to 90 
carbons for each chain) and is linked to AG. A study by Rao et al. (2005) has shown 
that a component of MAs (trans-cyclopropanation) suppresses inflammation caused 
by M. tuberculosis infection (Rao et al. 2005, Hett, Rubin 2008).  
The Mycobacterium genus is also grouped as high G+C content bacteria with 
an average of 61 to 71 mol% G+C for all member species except 57 mol% for M. 
leprae. The genome size varies from species to species ranging from 4 to 7 million 
base pair (bp) (Table 1.3). Ninety percent (90%) of the genome represents coding 
regions that potentially encode for more than 6000 proteins (Cole et al. 1998, 
Zakham et al. 2011). Natural division and growth of Mycobacterium species differs 
based on slowly-growing to rapidly-growing characteristics. Slowly-growing 
Mycobacterium (SGM) requires more than 7 days for visible growth to appear as 
opposed to rapidly-growing Mycobacterium (RGM) which requires less than 7 days 
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when grown on Löwenstein-Jensen (L~J) medium. However, the RGM may require 
more than a week if grown from a clinical specimen (Brown-Elliott, Wallace 2011).  
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Figure 1.3: Schematic diagram of Mycobacterium showing the main components of 
the outer and inner layer of cell walls. The presence of mycolic acid in the complex 
of covalent-linked MA-AG-PG is a unique character for identification of the genus 
Mycobacterium and plays an important role as a permeability barrier (Medjahed, 
Gaillard & Reyrat 2010). 
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Table 1.3: List of selected Mycobacterium spp. showing variations in size and genome composition from species to species. This data was 
analysed and summarized from Genome Atlas Database (http://www.cbs.dtu.dk/services/GenomeAtlas). 
Organism 
 
Total size 
(bp) 
Number of 
genes 
Number of 
estimated 
proteins 
G+C (%) 16S 
rRNA 
count 
23S 
rRNA 
count 
NCBI 
project ID 
        
M. abscessus 5,090,491 4,941 1,030 64 1 1 15691 
M. avium 104 5,475,491 5,120 1,069 69 1 1 88 
M. bovis BCG str. Pasteur 1173P2 4,374,522 3,988 3,464 66 1 1 1173P2 
M. leprae Br4932 3,268,071 3,720 1,202 58 1 1 31271 
M. marinum M 6,660,144 5,452 1,222 66 1 1 16725 
M. smegmatis str MC
2
 155 6,988,209 6,716 5,614 68 2 2 92 
M. tuberculosis H37Ra 4,419,977 4,034 1,096 66 1 1 18883 
M. ulcerans Agy99 5,805,761 4,241 1,378 65 1 1 16230 
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1.3 Epidemiology and transmission. 
Members of the Mycobacterium genus are incapable of replicating in 
inanimate environments. For the MTBC and M. leprae, replication occurs in tissues 
of human and warm-blooded animals. The risk of infection is dependent on the load 
of the bacillus that has been inhaled, levels of infectiousness, person-to-person 
contacts and the immune level of the potential host.  This air-borne pathogen is 
transmitted from an active pulmonary tuberculosis patient by expectoration (cough). 
The droplet nuclei, approximately 1 to 5 µm in size “meander” in the air and are 
transmitted to the susceptible person by inhalation (Figure 1.4).  
The primary route of infection is the lungs. Tuberculosis can also infect other 
vital organs of human body such as kidney, spine and brain. Due to the relatively 
small size of the droplets inhaled into the lungs, the infection penetrates the defence 
system of bronchi and enters the terminal alveoli. These are then engulfed by 
alveolar macrophage and dendritic cells. The cell-mediated immune response arrests 
the multiplication of M. tuberculosis and stops infection. An infected person with a 
strong immune system is able to combat the infection within 2 to 8 weeks post-
infection, when the active cell-mediated immune response alleviates multiplication 
of M. tuberculosis. However, in some patients, the tubercle bacilli are latently 
infected with asymptomatic appearance. This occurs when the tubercle (infected 
macrophage or granuloma) is not completely eradicated by the immune system. 
Therefore, the tubercles remain in the system for a longer period of time. This type 
of infection is called latent tuberculosis.  
The latently infected person is non-infectious however the infection can be 
detected by tuberculin skin test (TST), and interferon gamma (IFN-γ) release assays 
(IGRA). While latent tuberculosis has a low potential to cause recurrent infection 
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(10%), it has been reported that reactivation of latent tuberculosis (active 
tuberculosis) may possibly happen after years of post-infection. The risk of 
reactivation is greater in HIV infected patients (15%) (Ahmad 2011). Studies have 
shown that, the pathogen enables the intracellular replication before responses of the 
immune system occurs in the lymph nodes and other extra pulmonary sites. This is 
an extraordinary ability that M. tuberculosis has to allow persistence and avoid 
eradication by host-immune system (Ahmad 2011, Obregon-Henao et al. 2012). 
Unlike M. tuberculosis, non-tuberculous mycobacteria (NTM) are live in 
moist habitats such as lakes, rivers and damp-soil. For example, M. avium complex 
(MAC), M. genavense, M. kansasii, M. xenopi, M. simiae, M. gordonae and some 
RGM have been recovered from tap water (Han, De & Jacobson 2007, Esteban et al. 
2008, Stout et al. 2011). Some NTM play important roles in nosocomial disease and 
pseudo-outbreaks. A recent study showed that NTM may be isolated from skin, 
upper respiratory tract, intestinal tract and genital tract and shows no symptoms to 
individuals (Lim, Kim & Yang 2012). Although the presence of NTM is not 
significant it indicates effects of infection and due to their ubiquity nature, their 
clinical significance is worth noting. 
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Figure 1.4: The flow-chart shows natural cause progression of tuberculosis and general plan-of-detection in immunocompetent and 
immunocompromised individual following exposure to tubercle bacilli by inhalation.   
* TST and QuantiFERON-TB Gold test are commonly used for 
immunodiagnostic test.  
**Both immunodiagnostic and acid-fast bacilli (AFB) microscopy results 
analysis. 
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1.4 Clinical significance. 
1.4.1 Slowly-growing mycobacteria (SGM). 
The higher prevalence of MTBC is known to involve several factors such as 
poverty, individual movement from high-risk countries, close-contact with infected 
tuberculosis patients and reactivation of latent tuberculosis among HIV infected 
persons (Pfyffer, Palicova 2011, Knechel 2009). MTBC consists of M. tuberculosis, 
M. bovis, M. bovis BCG (bacillus Calmette-Guérin), M. africanum M. caprae, M. 
microti, M. canettii and M. pinnipedii. They share genetic homology with no 
significant variation between sequences (~0.01 to 0.03%) although they have 
characterized difference with phenotypes (Homolka et al. 2008). Although all 
members of MTBC cause infection of humans, M. bovis, M. bovis BCG, M. microti 
and M. pinnipedii commonly infect warm-blooded animal as their primary host. It is 
likely that transmission occurs from animal to human (de la Rua-Domenech 2006, 
Leung et al. 2008, Kiers et al. 2008). Primarily, the animal to human tuberculosis 
transmission cases have been found from people who have worked or resided in the 
particular environment (Miltgen et al. 2002, Cvetnic et al. 2007, Romero et al. 2007, 
Kiers et al. 2008, Schoepf et al. 2012).    
In adults, tuberculosis progression is slow. Tuberculosis infection shows 
several significant clinical manifestations in pulmonary and extrapulmonary sites 
(Knechel 2009). Prolonged coughing, severe weigh-lost, night sweats, low-grade 
fever, dyspnoea and chest pain are clinical symptoms indicated from pulmonary 
infections. The extrapulmonary manifestation of M. tuberculosis infection includes 
meningitis, pleuritis, pericarditis, synovitis, cervical lymphadenitis and infections of 
the skin, joints, bones and internal organs (Fitzgerald, Sterling & Haas 2010, Ahmad 
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2011). In HIV infected tuberculosis patients, both types of clinical manifestation are 
significant due to the rapid progression of infection. 
M. africanum and M. canetti tuberculosis infection is mainly reported in 
tropical Africa (Miltgen et al. 2002, de Jong, Antonio & Gagneux 2010). It can be 
transmitted to western regions by migration of infected persons that used to live in 
Africa. Studies have shown that M. africanum can be subdivided into type I (M. 
bovis-like) and II (M. tuberculosis-like) based on chromosomal deletion distribution 
and geographic origin (Mostowy et al. 2004, de Jong, Antonio & Gagneux 2010). 
Infected patients have shown similar pulmonary clinical features regardless of type. 
Studies by de Jong et al. (2007) showed that a smear-positive tuberculosis patient 
identified various clinical and epidemiology differences between M. africanum type 
II and M. tuberculosis. Patients infected with this strain more likely showed major 
lung affects which were observed on chest X-rays regardless of a cough duration 
manifestation and occured in the group of older, HIV infected and malnourished 
patients (de Jong et al. 2007). M. canetti tuberculosis infection have also been highly 
reported in Africa with similar clinical features of the M. africanum infection. 
Although the main reservoir of M. canetti is unknown, patients show M. tuberculosis 
tuberculosis pulmonary clinical features and also lymphadenitis in tuberculosis 
infected children. Most of the cases have been reported from the continent of Africa 
(Miltgen et al. 2002). 
1.4.2 Rapidly-growing mycobacteria (RGM). 
The RGM are grouped as NTM and are opportunistic pathogens that can 
grow within 7 days in specific growth media. To date, more than 130 species of 
RGM have been found. Among these, several species have a clinical significance 
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and contribute to major health care-associated pseudo-outbreaks worldwide. 
Although many species have been identified as RGM, studies have shown that non-
pigmented RGM, M. fortuitum, M. chelonae and M. abscessus are pathogenic and 
responsible for disease in humans (Han, De & Jacobson 2007, Chan et al. 2010). 
Several cases have been reported due to the presence of RGM, commonly M. 
fortuitum, M. chelonae and M. abscessus and including less common (>10 clinical 
isolates or cases) human pathogenic RGM species; M. phocacium, M. mucogenicum 
and M. smegmatis group (known as sensu stricto). The common RGM 
species/groups cause health care-associated pseudo-outbreak diseases and are 
described in table 1.4. A study by Gayathri et al. (2010) has shown the in vitro 
antibiotic susceptibility testing among 148 RGM isolates and has indicated that a 
majority of RGM were sensitive to Amikacin (98%), Gatifloxacin (91%), 
Moxifloxacin (87%), Ciprofloxacin (76%) and Norfloxacin (Gayathri et al. 2010). 
Although the majority of health care-associated pseudo-outbreak diseases are 
treatable using antibiotics, the emergence of multidrug-resistant M. abscessus strains 
worsen the pseudo-outbreak infection scenario due to the most-virulent and 
chemotherapy-resistant strains (Leao et al. 2009, Gayathri et al. 2010). 
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Table 1.4: Most frequent human diseases caused by common RGM group/species (continued on next page). 
Organism Infection/disease Clinical features Potential host 
M. fortuitum 
group 
Post-traumatic wound Localized cutaneous, localized 
cellulitis or abscesses 
Normal or healthy patient undergone surgery 
 open fracture following bone and 
join surgery, 
Osteomyelitis, arthritis Metal puncture wound and motor accident patient 
related cases 
 Catheter infections Bacteremia Immunosuppressed patients receiving 
corticosteroid 
 Post-keratoplasty and LASIK 
surgery 
Keratitis Normal or healthy patient undergone surgery 
 Cosmetic/salon equipment 
contamination 
Furunculosis Normal or healthy patient exposed to 
contamination 
M. chelonae Post-surgical trauma Desseminated cutaneous, Immunosuppressed patients receiving 
corticosteroid 
 Catheter infections Hematogenous 
spread/bacteremia 
Immunosuppressed patients receiving 
corticosteroid 
 Chronic pulmonary infection Lipoid pneumonia Older non-smoking women on long-term 
corticosteroids therapy patient 
 Post-keratoplasty and LASIK 
surgery 
Keratitis Normal or healthy patient undergone surgery 
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Table 1.4: Most frequent human diseases caused by common RGM group/species (continued on next page). 
Organism Infection/disease Clinical features Potential host 
M. abscessus Post-traumatic wound Localized cutaneous 
 
immunosuppressed patients receiving 
corticosteroid 
 Post-surgical wound Chronic disseminated 
cutaneous 
Immunosuppressed patients 
  Otitis Ear tube placement surgical patients 
 Pulmonary Chronic lung infection Cyctic fibrosis, M. avium complex infected patient, 
non-smoking older women with bronchiectasis. 
Chronically immunosuppressed patients receiving 
corticosteriod 
 Catheter infections Multiple draining cutaneous 
nodules at lower extremities 
Immunosuppressed patients receiving 
corticosteroid 
 Post-keratoplasty and LASIK 
surgery 
Keratitis Normal or healthy patient undergone surgery 
M. smegmatis 
group 
Post-surgical or medical 
procedures, face-lift plastic 
surgery 
Cellulitis, localized abscess, Normal or healthy patient undergone surgery 
 Post-surgical open-fractures 
wound 
Osteomyelitis Normal or healthy patient undergone surgery 
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Table 1.4: Most frequent human diseases caused by common RGM group/species. 
Organism Infection/disease Clinical features Potential host 
M. 
mucogenicum 
Catheter infection Bacteremia Immunosuppressed patients receiving 
corticosteroids 
M. fortuitum 
biovarint 
complex 
Post-traumatic wound, Post-
surgical open-fractures wound 
Osteomyelitis Metal puncture wound and motor accident patient 
related cases 
LASIK= Laser-assisted in situ keratomileusis.
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1.5 A standard diagnosis of M. tuberculosis from clinical specimens. 
The most frequent type of sample in which the presence of M. tuberculosis is 
detected is respiratory expectorate or sputum. Samples are taken from potential 
patients after clinical manifestations are confirmed by chest X-rays, except for the 
HIV infected and elderly patients that do not show the typical pulmonary clinical 
features (Perkins, Cunningham 2007, Richter, Brown-Elliott & Wallace 2011). 
Conventionally, three sputum samples collected from persistent coughing patients 
are processed to ensure a large number of bacilli. Usually, there are a small numbers 
of bacilli present in body fluid samples. Therefore, the sample is suspended in sterile 
saline (0.85%) or bovine albumin (0.2%) and centrifuged (≥ 3,000 × g, 15 minutes) 
prior to inoculation of the sediment.  
M. tuberculosis detection from pre-processed samples is performed by acid-
fast staining to identify the presence of AFB. This is followed by culturing on solid 
media. Due to the slow-growing character of M. tuberculosis, at least 4 to 8 weeks 
are required for visible growth on solid media. The CDC has recommended that 
positive results from AFB smears must be reported after 24 hours of specimen 
receipt (Watterson, Drobniewski 2000, Knechel 2009). The standard culture media 
used in many diagnostic laboratories for identification of M. tuberculosis isolated 
from sputum samples is Löwenstein-Jensen (L~J) or Kirchner solid/liquid media and 
Middlebrook (7H9, 7H10 and 7H11) formulation. Following confirmation of 
tuberculosis from standard protocols, an AFB microscopy analysis must be 
performed to ensure the prescribed treatment is successful. However, it is 
unnecessary to obtain three samples to discontinue respiratory isolation. 
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